Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ATAI
12251
PUT
DELISTED
AtaiBeckley Inc
ATAI
| $55.3K | ﹤0.01% |
41,600
-8,700
| -17% | -$11.6K |
2021 Q3
13 quarters
|
|
|
GOEV
12252
CALL
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $55.2K | ﹤0.01% |
39,120
+18,857
| +93% | +$205K |
2020 Q3
17 quarters
|
|
12253
PUT
iShares MSCI Switzerland ETF
EWL
$2.68B
| $55.2K | ﹤0.01% |
1,200
+600
| +100% | +$29.3K |
2023 Q3
5 quarters
|
|
|
GELS
12254
Gelteq Ltd
GELS
$6.21M
| $55.1K | ﹤0.01% |
+23,748
| New | +$58K |
2024 Q4
0 quarters
|
|
12255
PUT
Aura Biosciences
AURA
$640M
| $55.1K | ﹤0.01% |
6,700
+2,000
| +43% | +$18.8K |
2023 Q2
6 quarters
|
|
|
ADIL
12256
Adial Pharmaceuticals
ADIL
$11.7M
| $55.1K | ﹤0.01% |
2,180
+849
| +64% | +$22.1K |
2024 Q2
2 quarters
|
|
12257
CALL
Hycroft Mining Holding Corp
HYMC
$1.78B
| $54.9K | ﹤0.01% |
24,840
-2,740
| -10% | -$6.48K |
2022 Q1
11 quarters
|
|
|
RJET
12258
CALL
Republic Airways Holdings
RJET
$824M
| $54.9K | ﹤0.01% |
3,153
+2,053
| +187% | +$31.8K |
2022 Q4
8 quarters
|
|
12259
CALL
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.11B
| $54.9K | ﹤0.01% |
+1,800
| New | +$57.7K |
2024 Q4
0 quarters
|
|
12260
CALL
Invesco DB Base Metals Fund
DBB
$364M
| $54.7K | ﹤0.01% |
2,900
-26,200
| -90% | -$531K |
2023 Q4
4 quarters
|
|
12261
PUT
CGI
GIB
$14.4B
| $54.7K | ﹤0.01% |
500
-1,100
| -69% | -$124K |
2022 Q4
8 quarters
|
|
12262
CALL
Puma Biotechnology
PBYI
$490M
| $54.6K | ﹤0.01% |
17,900
-15,500
| -46% | -$45.1K |
2022 Q3
9 quarters
|
|
12263
CALL
Alto Neuroscience
ANRO
$930M
| $54.6K | ﹤0.01% |
12,900
-27,400
| -68% | -$171K |
2024 Q3
1 quarter
|
|
12264
PUT
Colliers International
CIGI
$4.48B
| $54.4K | ﹤0.01% |
400
-400
| -50% | -$59.1K |
2022 Q4
8 quarters
|
|
|
LUNA
12265
DELISTED
Luna Innovations Incorporated
LUNA
| $54.3K | ﹤0.01% |
+25,129
| New | +$44.4K |
2024 Q4
0 quarters
|
|
|
TGB
12266
Trekor Metals
TGB
$3.22B
| $54.3K | ﹤0.01% |
27,974
-61,030
| -69% | -$134K |
2024 Q3
1 quarter
|
|
12267
CALL
Weis Markets
WMK
$1.8B
| $54.2K | ﹤0.01% |
800
-2,100
| -72% | -$145K |
2022 Q2
10 quarters
|
|
|
XAGE
12268
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
| $54.1K | ﹤0.01% |
+6,252
| New | +$59.4K |
2024 Q4
0 quarters
|
|
|
DSL
12269
CALL
DoubleLine Income Solutions Fund
DSL
$1.13B
| $54.1K | ﹤0.01% |
4,300
+2,900
| +207% | +$36.9K |
2023 Q1
7 quarters
|
|
12270
PUT
First Watch Restaurant Group
FWRG
$655M
| $54K | ﹤0.01% |
+2,900
| New | +$51.2K |
2024 Q4
0 quarters
|
|
12271
Xenetic Biosciences
XBIO
$4.97M
| $53.9K | ﹤0.01% |
+13,380
| New | +$54K |
2024 Q4
0 quarters
|
|
12272
PUT
Claros Mortgage Trust
CMTG
$171M
| $53.8K | ﹤0.01% |
11,900
+6,800
| +133% | +$42.4K |
2023 Q1
7 quarters
|
|
12273
ProShares UltraShort Gold
GLL
$92.7M
| $53.7K | ﹤0.01% |
764
-1,058
| -58% | -$72.2K |
2022 Q1
11 quarters
|
|
12274
CALL
Nomad Foods
NOMD
$1.53B
| $53.7K | ﹤0.01% |
3,200
-11,300
| -78% | -$197K |
2022 Q4
8 quarters
|
|
12275
Mammoth Energy Services
TUSK
$140M
| $53.6K | ﹤0.01% |
17,865
-47,425
| -73% | -$175K |
2024 Q2
2 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.